Community-acquired pneumonia in children

Early Human Development

Volumn 89, Issue SUPPL3, 2013, Pages

  Cardinale, Fabio ^a   Cappiello, Anna Rita ^a   Mastrototaro, Maria Felicia ^a   Pignatelli, Mariacristina ^a   Esposito, Susanna ^b  

^a POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Antibiotics; Antimicrobial treatment; Community acquired pneumonia; Pneumonia; Respiratory infection

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; AMPICILLIN; C REACTIVE PROTEIN; GENTAMICIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; PROCALCITONIN; QUINOLONE DERIVATIVE;

ADAPTIVE IMMUNITY; ARTICLE; BLOOD CULTURE; BOCAVIRUS; BORDETELLA PERTUSSIS; CHILDHOOD DISEASE; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY ACQUIRED PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; CORONAVIRUS; CRITICALLY ILL PATIENT; CYANOSIS; DISEASE COURSE; DISEASE SEVERITY; HAEMOPHILUS INFLUENZAE; HOST SUSCEPTIBILITY; HUMAN; HUMAN METAPNEUMOVIRUS; LEUKOCYTE DIFFERENTIAL COUNT; LUNG LAVAGE; MIXED INFECTION; MYCOPLASMA PNEUMONIAE; PATHOGEN LOAD; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; RADIATION EXPOSURE; RESPIRATORY DISTRESS; SCORING SYSTEM; SEROTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; STAPHYLOCOCCUS AUREUS; TACHYPNEA; THORAX RADIOGRAPHY; UPPER RESPIRATORY TRACT INFECTION; VACCINATION;

ANTIBIOTICS; ANTIMICROBIAL TREATMENT; COMMUNITY-ACQUIRED PNEUMONIA; PNEUMONIA; RESPIRATORY INFECTION;

CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; PNEUMONIA;

EID: 84887139561     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2013.07.023     Document Type: Article

References (33)

1. Esposito S., Cohen R., Domingo J.D., Pecurariu O.F., Greenberg D., Heininger U., et al. Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat?. Pediatr Infect Dis J 2012, 31:e78-e85.
2. Principi N., Esposito S. Management of severe community-acquired pneumonia of children in developing and developed countries. Thorax 2011, 66:815-822.
3. Esposito S., Marchese A., Tozzi A.E., Rossi G.A., Da Dalt L., Bona G., et al. Bacteremic pneumococcal community-acquired pneumonia in children less than 5years of age in Italy. Pediatr Infect Dis J 2012, 31:705-710.
4. Li S.T., Tancredi D.J. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics 2010, 125:26-33.
5. Finelli L., Fiore A., Dhara R., Brammer L., Shay D.K., Kamimoto L., et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008, 122:805-811.
6. Harris M., Clark J., Coote N., Fletcher P., Harnden A., McKean M., et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax 2011, 66(Suppl. 2):ii1-ii23.
7. Bradley J.S., Byington C.L., Shah S.S., Alverson B., Carter E.R., Harrison C., et al. Executive summary: the management of community-acquired pneumonia in infants and children older than 3months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011, 53:617-630.
8. Johnson J., Kline J.A. Intraobserver and interobserver agreement of the interpretation of pediatric chest radiographs. Emerg Radiol 2010, 17:285-290.
9. Ruuskanen O., Jennings L.C., Murdoch D.R. Viral pneumonia. Lancet 2011, 377:1264-1275.
10. Esposito S., Principi N. Unsolved problems in the approach to pediatric community-acquired pneumonia. Curr Opin Infect Dis 2012, 25:286-291.
11. Esposito S., Daleno C., Prunotto G., Scala A., Tagliabue C., Borzani I., et al. Impact of viral infections in children with community-acquired pneumonia: results of a study of 17 respiratory viruses. Influenza Other Respi Viruses 2013, 7:18-26.
12. McIntosh K. Community acquired pneumonia in children. N Engl J Med 2002, 346:429-437.
13. Esposito S., Bosis S., Cavagna R., Faelli N., Begliatti E., Marchisio P., et al. Characteristics of Streptococcus pneumonia and atypical bacterial infections in children 2-5years of age with community-acquired pneumonia. Clin Infect Dis 2002, 35:1345-1352.
14. Michelow I.C., Olsen K., Lozano J., Rollins N.K., Duffy L.B., Ziegler T., et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004, 113:701-707.
15. Tsolia M.N., Psarras S., Bossios A., Audi H., Paldanius M., Gourgiotis D., et al. Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis 2004, 39:681-686.
16. Perez-Trallero E. Viruses in community-acquired pneumonia in children aged less than 3years old: high rate of viral coinfection. J Med Virol 2008, 80:1843-1849.
17. Hedlund J.U., Ortqvist A.B., Kalin M., Scalia-Tomba G., Giesecke J. Risk of pneumonia in patients previously treated in hospital for pneumonia. Lancet 1992, 340:396-397.
18. Teepe J., Grigoryan L., Verheij T.J.M. Determinants of community-acquired pneumonia in children and young adults in primary care. Eur Respir J 2010, 35:1113-1117.
19. Petersen L., Andersen P.K., Sørensen T.I.A. Genetic influences on incidence and case-fatality of infectious disease. PLoS One 2010, 5:e10603.
20. Burgner D., Jamieson S.E., Blackwell J.M. Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better?. Lancet Infect Dis 2006, 6:653-663.
21. Garcia-Laorden M.I., Sole-Violan J., Rodriguez de Castro F., Aspa J., Briones M.L., Garcia-Saavedra A. Mannose-binding lectin and mannose-binding lectin-associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults. J Allergy Clin Immunol 2008, 122:368-374.
22. Gallagher P.M., Lowe G., Fitzgerald T., Bella A., Greene C.M., McElvaney N.G., et al. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax 2003, 58:154-156.
23. Hawn T.R., Verbon A., Lettinga K.D., Zhao L.P., Li S.S., Laws R.J., et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med 2003, 198:1563-1572.
24. Chapman S.J., Khor C.C., Vannberg F.O., Frodsham A., Walley A., Maskell N.A., et al. IκB genetic polymorphisms and invasive pneumococcal disease. Am J Respir Crit Care Med 2007, 176:181-187.
25. Yuan F.F., Wong M., Pererva N., Keating J., Davis A.R., Bryant J.A., et al. Fc-gammaRIIA polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol 2003, 81:192-195.
26. Yee A.M., Phan H.M., Zuniga R., Salmon J.E., Musher D.M. Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia. Clin Infect Dis 2000, 30:25-28.
27. Khor C.C., Chapman S.J., Vannberg F.O., Dunne A., Murphy C., Ling E.Y., et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet 2007, 39:523-528.
28. Khor C.C., Vannberg F.O., Chapman S.J., Guo H., Wong S.H., Walley A.J., et al. CISH and susceptibility to infectious diseases. N Engl J Med 2010, 362:2092-2101.
29. Krüger S., Ewig S., Kunde J., Hartmann O., Suttorp N., Welte T., et al. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ. Thorax 2010, 65:208-214.
30. Travaglino F., De Berardinis B., Magrini L., Bongiovanni C., Candelli M., Gentiloni Silveri N., et al. Utility of procalcitonin (PCT) and mid regional pro-adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score. BMC Infect Dis 2012, 12:184.
31. Ruiz-González A., Esquerda A., Falguera M., Abdulghani N., Cabezas P., Bielsa S., et al. Triggering receptor (TREM-1) expressed on myeloid cells predicts bacteremia better than clinical variables in community-acquired pneumonia. Respirology 2011, 16:321-325.
32. Reißig A., Copetti R., Mathis G., Mempel C., Schuler A., Zechner P., et al. Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia. A prospective multicentre diagnostic accuracy study. Chest 2012, 142:965-972.
33. Esposito S., Tagliabue C., Picciolli I., Semino M., Sabatini C., Consolo S., et al. Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia. Respir Med 2011, 105:1939-1945.